IN2012DN00401A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00401A
IN2012DN00401A IN401DEN2012A IN2012DN00401A IN 2012DN00401 A IN2012DN00401 A IN 2012DN00401A IN 401DEN2012 A IN401DEN2012 A IN 401DEN2012A IN 2012DN00401 A IN2012DN00401 A IN 2012DN00401A
Authority
IN
India
Prior art keywords
unit
repetition
electrode carrier
hexagon
electrodes
Prior art date
Application number
Other languages
English (en)
Inventor
Manuel Soto-Alvarez
Garcia Laura Ramirez
Eduardo Antonio Ferraz Coelho
Carlos Alonso-Bedate
Original Assignee
Leti Sl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti Sl Lab filed Critical Leti Sl Lab
Publication of IN2012DN00401A publication Critical patent/IN2012DN00401A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Secondary Cells (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN401DEN2012 2009-07-13 2010-07-13 IN2012DN00401A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09165282 2009-07-13
US26721409P 2009-12-07 2009-12-07
PCT/EP2010/060058 WO2011006891A1 (fr) 2009-07-13 2010-07-13 Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)

Publications (1)

Publication Number Publication Date
IN2012DN00401A true IN2012DN00401A (fr) 2015-08-21

Family

ID=41211952

Family Applications (1)

Application Number Title Priority Date Filing Date
IN401DEN2012 IN2012DN00401A (fr) 2009-07-13 2010-07-13

Country Status (20)

Country Link
US (1) US8969019B2 (fr)
EP (1) EP2454593A1 (fr)
JP (1) JP5805635B2 (fr)
KR (1) KR20120061082A (fr)
CN (1) CN102483413A (fr)
AP (1) AP3516A (fr)
AU (1) AU2010272566B2 (fr)
BR (1) BR112012000679A2 (fr)
CA (1) CA2767865A1 (fr)
CO (1) CO6480993A2 (fr)
EC (1) ECSP12011662A (fr)
IL (1) IL217528A (fr)
IN (1) IN2012DN00401A (fr)
MA (1) MA33514B1 (fr)
MX (1) MX2012000675A (fr)
PE (1) PE20120818A1 (fr)
RU (1) RU2558233C2 (fr)
TN (1) TN2012000014A1 (fr)
WO (1) WO2011006891A1 (fr)
ZA (1) ZA201200295B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
JP2016053535A (ja) * 2014-09-04 2016-04-14 国立大学法人 東京大学 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en) * 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
PT1141305E (pt) * 1998-12-23 2006-10-31 Leti Lab Gene quimerico formado pelas sequencias de adn que codifica os determinantes antigenicos de quatro proteinas de l. infantum
SI1141305T1 (sl) * 1998-12-23 2006-10-31 Leti Lab Himerni gen, ki kodira antigenske determinante stirih proteinov L. Infantum
ES2169995B1 (es) 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
CA2498604A1 (fr) * 2002-09-20 2004-04-01 Akzo Nobel N.V. Vaccin de parasite vivant attenue
WO2005044301A2 (fr) 2003-11-05 2005-05-19 C.B.F. Leti, S.L. Unipersonal Application d'histones specifiques au traitement de maladies parasitaires

Also Published As

Publication number Publication date
TN2012000014A1 (en) 2013-09-19
AP3516A (en) 2016-01-11
KR20120061082A (ko) 2012-06-12
JP5805635B2 (ja) 2015-11-04
CO6480993A2 (es) 2012-07-16
PE20120818A1 (es) 2012-07-12
MA33514B1 (fr) 2012-08-01
RU2558233C2 (ru) 2015-07-27
EP2454593A1 (fr) 2012-05-23
AP2012006118A0 (en) 2012-02-29
MX2012000675A (es) 2012-06-08
US8969019B2 (en) 2015-03-03
BR112012000679A2 (pt) 2016-11-01
US20120178109A1 (en) 2012-07-12
JP2012533074A (ja) 2012-12-20
AU2010272566B2 (en) 2015-03-26
CN102483413A (zh) 2012-05-30
RU2012104855A (ru) 2013-08-20
ECSP12011662A (es) 2012-06-29
AU2010272566A1 (en) 2012-02-02
WO2011006891A1 (fr) 2011-01-20
CA2767865A1 (fr) 2011-01-20
IL217528A (en) 2016-05-31
IL217528A0 (en) 2012-02-29
ZA201200295B (en) 2012-09-26

Similar Documents

Publication Publication Date Title
EP2898846A3 (fr) Système électrochirurgical avec un amplificateur de fréquence radio
EP2505136A4 (fr) Dispositif d'électrode pour mesurer l'impédance à l'intérieur du corps humain, et appareil utilisant un tel dispositif à pour mesurer l'impédance à l'intérieur du corps humain et effectuer un traitement
EP2382938A3 (fr) Plaque de scellage isolée
EP3951959B8 (fr) Collecteur de courant d'électrode positive, plaque d'électrode positive, dispositif électrochimique et appareil
EP3243470A3 (fr) Ablation simultanée par de multiples électrodes
EP4603069A3 (fr) Electrode pour stimulation musculaire
WO2011010148A3 (fr) Améliorations apportées à la réduction et l'élimination de particules
WO2013026884A3 (fr) Dispositif électrochirurgical et procédés de fabrication et d'utilisation
WO2011075485A3 (fr) Instrument chirurgical comportant une électrode
EP2375020A3 (fr) Structure en nid d'abeille
EP2369902A3 (fr) Appareil de génération de plasma
PH12016500212A1 (en) Therapeutic electron and ion transfer via half-cell
EP2526886A3 (fr) Dispositif de retrait de tissu endovasculaire
EP3879600A4 (fr) Matériau d'électrode positive, dispositif électrochimique le comprenant et dispositif électronique
EP2267806A3 (fr) Assemblage piézoélectrique
EP4254556A4 (fr) Matériau d'électrode positive, dispositif électrochimique et dispositif électronique
EP4439720A4 (fr) Matériau actif d'électrode positive, dispositif électrochimique et dispositif électronique
EP4231387A4 (fr) Électrode positive, et dispositif électrochimique et dispositif électronique comprenant celle-ci
EP2265204A4 (fr) Procédés et appareil de traitement électrique utilisant un ballon et une électrode
EP3930057A4 (fr) Collecteur de courant d'électrode positive, plaque d'électrode positive, appareil électrochimique et dispositif associé
EP4428953A4 (fr) Matériau actif d'électrode positive, plaque d'électrode positive, appareil électrochimique comprenant une plaque d'électrode positive, et appareil électronique
NZ597967A (en) Device and method for surface processing having a test station
EP4421932A4 (fr) Plaque d'électrode positive, dispositif électrochimique et dispositif électronique
IN2012DN00401A (fr)
EP4273950A4 (fr) Plaque d'électrode, dispositif électrochimique et dispositif électronique